Citizens Financial Group (CFG)

NYSEFinancialsBanks - RegionalSnapshot 2026-10-15

$63.36-0.11%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Citizens Financial Group’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.1%

+10% or more+5%0%−5%−10% or less

6.50 → 6.49 EPS · FY ending Dec 31, 2027 · 14 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 12 to 14; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Improve efficiency ratio to 63.6 or better	Efficiency ratio improved from 67.9 to 63.6, showing better cost control.	Intact	efficiency ratio rises above 67.9%	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 7 of last 7 quarters. Efficiency ratio improved from 67.9% in 2025-Q1 to 61.1% in 2026-Q2, reflecting disciplined expense management despite investments in growth and technology. Noninterest expense increased modestly by 1% QoQ to $1.394B in 2026-Q2. Management has maintained focus on efficiency, and the financials show delivering progress. Delivery assessment Oct 15, 2026
Maintain net interest margin near 3.14%	Profit margins improved to 3.14% net interest margin.	Intact	net interest margin falls below 2.90%	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Grow noninterest income to at least $606M	Noninterest income rose from $544M to $606M.	Intact	noninterest income falls below $544M	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 7 of last 7 quarters. Noninterest income grew from $544M in 2025-Q1 to $652M in 2026-Q2 (+20%), with Capital Markets fees reaching a record $153M in 2026-Q2, up $19M QoQ. Wealth fees also showed steady growth. Management consistently emphasized fee growth driven by Capital Markets and Wealth, and financials confirm delivering progress. Delivery assessment Oct 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$6.49

$6.51 → $6.49 · observed estimates

FY2027 revenue$9.98B

$9.97B → $9.98B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$6.51	$9,969,634,570	13 / 9
2026-07-25	$6.51	$9,969,634,570	13 / 9
2026-07-26	$6.51	$9,969,634,570	13 / 9
2026-07-27	$6.51	$9,969,634,570	13 / 9
2026-07-28	$6.51	$9,969,634,570	13 / 9
2026-07-29	$6.51	$9,969,634,570	13 / 9
2026-07-30	$6.50	$9,970,383,291	12 / 7
2026-07-31	$6.50	$9,975,162,407	12 / 7
2026-08-01	$6.51	$9,977,637,000	13 / 9
2026-08-02	$6.51	$9,977,637,000	13 / 9
2026-08-03	$6.50	$9,975,162,407	12 / 7
2026-08-04	$6.50	$9,975,162,407	12 / 7
2026-08-05	$6.50	$9,975,162,407	12 / 7
2026-08-06	$6.50	$9,975,162,407	12 / 7
2026-08-07	$6.50	$9,975,162,407	12 / 7
2026-08-08	$6.50	$9,975,162,407	12 / 7
2026-08-09	$6.50	$9,975,162,407	12 / 7
2026-08-10	$6.50	$9,975,162,407	12 / 7
2026-08-11	$6.51	$9,980,308,480	12 / 9
2026-08-12	$6.50	$9,975,162,407	12 / 7
2026-08-13	$6.51	$9,980,308,480	12 / 9
2026-08-14	$6.50	$9,975,162,407	12 / 7
2026-08-15	$6.50	$9,975,162,407	11 / 7
2026-08-16	$6.50	$9,975,162,407	11 / 7
2026-08-17	$6.50	$9,975,162,407	11 / 7
2026-08-18	$6.50	$9,975,162,407	11 / 7
2026-08-19	$6.50	$9,975,162,407	11 / 7
2026-08-20	$6.50	$9,976,776,006	11 / 6
2026-08-21	$6.50	$9,976,776,006	11 / 6
2026-08-22	$6.50	$9,976,776,006	11 / 6
2026-08-23	$6.50	$9,976,776,006	11 / 6
2026-08-24	$6.50	$9,976,776,006	11 / 6
2026-08-25	$6.50	$9,976,776,006	11 / 6
2026-08-26	$6.50	$9,976,776,006	11 / 6
2026-08-27	$6.50	$9,976,776,006	11 / 6
2026-08-28	$6.50	$9,976,776,006	11 / 6
2026-08-29	$6.50	$9,976,776,006	11 / 6
2026-08-30	$6.50	$9,976,776,006	11 / 6
2026-08-31	$6.50	$9,976,776,006	11 / 6
2026-09-01	$6.50	$9,976,776,006	11 / 6
2026-09-02	$6.50	$9,976,776,006	11 / 6
2026-09-03	$6.50	$9,976,776,006	11 / 6
2026-09-04	$6.50	$9,976,776,006	11 / 6
2026-09-05	$6.50	$9,975,842,672	12 / 6
2026-09-06	$6.50	$9,975,842,672	12 / 6
2026-09-07	$6.50	$9,975,842,672	12 / 7
2026-09-08	$6.50	$9,975,842,672	12 / 7
2026-09-09	$6.50	$9,981,622,777	12 / 7
2026-09-10	$6.50	$9,979,622,777	12 / 7
2026-09-11	$6.50	$9,979,622,777	12 / 7
2026-09-12	$6.50	$9,979,622,777	12 / 7
2026-09-13	$6.50	$9,979,622,777	12 / 7
2026-09-14	$6.50	$9,979,622,777	12 / 7
2026-09-15	$6.50	$9,979,622,777	12 / 7
2026-09-16	$6.50	$9,979,622,777	12 / 7
2026-09-17	$6.50	$9,979,622,777	12 / 7
2026-09-18	$6.50	$9,979,622,777	12 / 7
2026-09-19	$6.50	$9,979,622,777	12 / 7
2026-09-20	$6.50	$9,979,622,777	12 / 7
2026-09-21	$6.50	$9,979,622,777	12 / 7
2026-09-22	$6.50	$9,979,622,777	12 / 7
2026-09-23	$6.50	$9,980,303,457	12 / 7
2026-09-24	$6.50	$9,980,303,457	12 / 7
2026-09-25	$6.50	$9,981,086,450	12 / 7
2026-09-26	$6.50	$9,977,976,102	12 / 7
2026-09-27	$6.50	$9,977,976,102	12 / 7
2026-09-28	$6.50	$9,977,976,102	12 / 7
2026-09-29	$6.50	$9,975,458,341	12 / 7
2026-09-30	$6.50	$9,975,458,341	12 / 7
2026-10-01	$6.50	$9,976,991,674	13 / 8
2026-10-02	$6.50	$9,976,978,341	13 / 8
2026-10-03	$6.51	$9,974,670,904	13 / 8
2026-10-04	$6.51	$9,974,670,904	13 / 8
2026-10-05	$6.51	$9,974,670,904	13 / 8
2026-10-06	$6.50	$9,971,930,311	13 / 8
2026-10-07	$6.50	$9,971,396,978	13 / 8
2026-10-08	$6.50	$9,977,303,407	14 / 8
2026-10-09	$6.50	$9,978,785,560	14 / 9
2026-10-10	$6.50	$9,978,785,560	14 / 9
2026-10-11	$6.50	$9,978,785,560	15 / 8
2026-10-12	$6.50	$9,978,785,560	15 / 8
2026-10-13	$6.50	$9,978,785,560	15 / 8
2026-10-14	$6.50	$9,978,785,560	15 / 8
2026-10-15	$6.49	$9,978,785,560	14 / 8

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	17	1
2026-06-01	16	2
2026-07-01	16	3
2026-08-01	15	3
2026-09-01	15	3
2026-10-01	17	3

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 17 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades6 maintains

Recent actions · Sep 16–Oct 15 · 6 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Cantor FitzgeraldOct 14 · prior Aug 19

$84.00 → $78.00-7.1%

Raymond JamesOct 6

$77.00New observation · no comparable prior

UBSOct 5

$77.00New observation · no comparable prior

Evercore ISIOct 1 · prior Jul 6

$80.00 → $78.00-2.5%

Morgan StanleySep 28 · prior Sep 8

$90.00 → $89.00-1.1%

Truist FinancialSep 23 · prior Jul 21

$80.00 → $77.00-3.7%

$0$49.50$99.00

0 raises · 4 cuts · 0 unchanged · 2 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Improve efficiency ratio to 63.6 or betterDirect metric needs a verified mapping
Maintain net interest margin near 3.14%Direct metric needs a verified mapping
Grow noninterest income to at least $606MDirect metric needs a verified mapping

Next proof point

Oct 16, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.9%Typical daily move · historical

Downside history

-18.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Citizens Financial Group outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a durable compounder with a focus on growth in net interest income and noninterest income. The current thesis state is intact, supported by recent strong financial performance.

What's priced into Citizens Financial Group

The market seems to have priced in a neutral valuation, with CFG appearing cheap compared to its peers. However, there is a slight expectations gap, indicating that some cautious sentiment may be reflected in the stock.

What the fundamentals likely do

Management is on track with its priorities, including growing net interest income and enhancing noninterest income. Recent financial performance has been strong, but there is a moderate risk of missing future estimates due to past performance.

What Citizens Financial Group hinges on

The long-term thesis hinges on management's ability to maintain guidance and the performance of sector bellwethers. If CFG cuts guidance or if the Federal Reserve lowers interest rates, it could negatively impact the stock.